ROBERT J. ANDERSON, M.D.; HSIAO-MIN CHUNG, M.D.; RUDIGER KLUGE, M.D.; ROBERT W. SCHRIER, M.D.
ANDERSON RJ, CHUNG H, KLUGE R, SCHRIER RW. Hyponatremia: A Prospective Analysis of Its Epidemiology and the Pathogenetic Role of Vasopressin. Ann Intern Med. 1985;102:164-168. doi: 10.7326/0003-4819-102-2-164
Download citation file:
Published: Ann Intern Med. 1985;102(2):164-168.
We prospectively evaluated the frequency, cause, and outcome of hyponatremia (plasma sodium concentration, < 130 meq/L), as well as the hormonal response to this condition, in hospitalized patients. Daily incidence and prevalence of hyponatremia averaged 0.97% and 2.48%, respectively. Two thirds of all hyponatremia was hospital acquired. Normovolemic states (so-called syndrome of inappropriate secretion of antidiuretic hormone) were the most commonly seen clinical setting of hyponatremia. The fatality rate for hyponatremic patients was 60-fold that for patients without documented hyponatremia. Nonosmotic secretion of vasopressin was present in 97% of hyponatremic patients in whom it was sought. In edematous and hypovolemic patients, plasma hormonal responses (increases in plasma renin activity and aldosterone and norepinephrine levels) were compatible with baroreceptor-mediated release of vasopressin. Hyponatremia is a common hospital-acquired electrolyte disturbance that is an indicator of poor prognosis. Nonosmotic secretion of arginine vasopressin is a major pathogenetic factor in this electrolyte disturbance.
Learn more about subscription options.
Register Now for a free account.
Endocrine and Metabolism, Fluid and Electrolyte Disorders, Nephrology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only